NCT00701311View on ClinicalTrials.gov

An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

March 31, 2011

Conditions

ProstatitisChronic Prostatitis With Chronic Pelvic Pain Syndrome

Interventions

DRUG

CC-10004

CC-10004 20 mg per day

Trial Locations (1)

48073

William Beaumont Hospital, Royal Oak

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Kenneth Peters, MD

OTHER